Literature DB >> 28947044

Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization.

Tadahiro Goto1, Mohammad Kamal Faridi2, Koichiro Gibo3, Carlos A Camargo4, Kohei Hasegawa5.   

Abstract

BACKGROUND: Reduction of 30-day readmissions in patients hospitalized for chronic obstructive pulmonary disease (COPD) is a national objective. However, there is a dearth of research on sex and racial/ethnic differences in the reason for 30-day readmission.
METHODS: We conducted a retrospective cohort study using 2006-2012 data from the State Inpatient Database of eight geographically-diverse US states (Arkansas, California, Florida, Iowa, Nebraska, New York, Utah, and Washington). After identifying all hospitalizations for COPD made by patients aged ≥40 years, we investigated the primary diagnostic code for all-cause readmissions within 30 days after the original COPD hospitalization, among the overall group and by sex and race/ethnicity strata.
RESULTS: Between 2006 and 2012, there was a total of 845,465 COPD hospitalizations at risk for 30-day readmissions in the eight states. COPD was the leading diagnostic for 30-day readmission after COPD hospitalization, both overall (28%) and across all sex and race/ethnicity strata. The proportion of respiratory diseases (COPD, pneumonia, respiratory failure, and asthma) as the readmission diagnosis was higher in non-Hispanic black (55%), compared to non-Hispanic white (52%) and Hispanics (51%) (p < 0.001). The proportion of asthma as the readmission diagnosis differed significantly by sex (6% in men and 9% in women; p < 0.001). Similarly, the proportion of asthma also differed significantly by race/ethnicity (5% in non-Hispanic white, 16% in non-Hispanic black, 15% in Hispanics, 13% in others; p < 0.001).
CONCLUSIONS: In this analysis of all-payer population-based data, we found sex and racial/ethnic differences in the reason for 30-day readmission in patients hospitalized for COPD.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  30-day readmission; COPD; Racial/ethnic differences; Sex differences

Mesh:

Year:  2017        PMID: 28947044      PMCID: PMC5991795          DOI: 10.1016/j.rmed.2017.07.056

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

Review 1.  International classification of disease coding for obstructive lung disease: does it reflect appropriate clinical documentation?

Authors:  Philip Marcus; Sidney S Braman
Journal:  Chest       Date:  2010-07       Impact factor: 9.410

2.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

3.  Asthma/COPD Overlap Syndrome and Medicare 30-Day Readmissions.

Authors:  Jordan B Glaser; Bhavi Pandya; Mark Jarrett
Journal:  Ann Am Thorac Soc       Date:  2016-07

4.  Readmissions, Observation, and the Hospital Readmissions Reduction Program.

Authors:  Rachael B Zuckerman; Steven H Sheingold; E John Orav; Joel Ruhter; Arnold M Epstein
Journal:  N Engl J Med       Date:  2016-02-24       Impact factor: 91.245

5.  Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion.

Authors:  Tina Shah; Matthew M Churpek; Marcelo Coca Perraillon; R Tamara Konetzka
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

6.  Penalizing hospitals for chronic obstructive pulmonary disease readmissions.

Authors:  Laura C Feemster; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

Review 7.  Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment.

Authors:  deNay P Kirkpatrick; Mark T Dransfield
Journal:  Curr Opin Pulm Med       Date:  2009-03       Impact factor: 3.155

8.  The prevalence and incidence of asthma and asthma-like symptoms in a general population sample.

Authors:  R R Dodge; B Burrows
Journal:  Am Rev Respir Dis       Date:  1980-10

9.  The clinical and genetic features of COPD-asthma overlap syndrome.

Authors:  Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  Eur Respir J       Date:  2014-05-29       Impact factor: 16.671

Review 10.  The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?

Authors:  Konstantinos Kostikas; Andreas Clemens; Francesco Patalano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-16
View more
  4 in total

1.  Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Brett C Bade; Eric C DeRycke; Christine Ramsey; Melissa Skanderson; Kristina Crothers; Sally Haskell; Bevanne Bean-Mayberry; Cynthia Brandt; Lori A Bastian; Kathleen M Akgün
Journal:  Ann Am Thorac Soc       Date:  2019-06

2.  Readmission within three months after inpatient geriatric care-Incidence, diagnosis and associated factors in a Swedish cohort.

Authors:  Carl Willers; Anne-Marie Boström; Lennart Carlsson; Anton Lager; Rikard Lindqvist; Elisabeth Rydwik
Journal:  PLoS One       Date:  2021-03-22       Impact factor: 3.240

3.  Hospital readmissions in Internal Medicine Specialty: Frequency, associated factors and outcomes.

Authors:  Samar Fatima; Sara Shamim; Simra Raffat; Muhammad Tariq
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

4.  Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population.

Authors:  Aatish Patel; Ahmed Abdulaal; David Ariyanayagam; Kieran Killington; Sarah J Denny; Nabeela Mughal; Stephen Hughes; Nupur Goel; Gary W Davies; Luke S P Moore; Esmita Charani
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.